Skip to main content
. 2018 Sep 21;49:96. doi: 10.1186/s13567-018-0590-2

Figure 4.

Figure 4

Comparison of SLA-DR expression levels by immunohistochemical analysis. Primary PAMs, PAM61 (A) and PAM303 (B); immortalized PAMs, iPAM61 (A) and iPAM303 (B). Control cells, 3D4/21 (C) and PK15 (C). The first, second, and third columns show the results from DAPI staining with anti-SLA-DR specific antibody. The third column indicates merged images with ×20 magnification. Scale bar: 100 µm.